調査レポート | • レポートコード：QYR2104Z1067 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、がんゲノム配列決定のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（第二世代、第三世代）、用途別市場規模（治療、研究）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・がんゲノム配列決定の市場動向 ・企業の競争状況、市場シェア ・がんゲノム配列決定の種類別市場規模（第二世代、第三世代） ・がんゲノム配列決定の用途別市場規模（治療、研究） ・がんゲノム配列決定の北米市場規模2016-2027（アメリカ、カナダ） ・がんゲノム配列決定のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・がんゲノム配列決定のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・がんゲノム配列決定の中南米市場規模2016-2027（メキシコ、ブラジル） ・がんゲノム配列決定の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Agilent Technologies、GE Healthcare Life Sciences、Johnson & Johnson、LI-COR Biosciences、Abbott Laboratories、Beckman Coulter、Bayer、Hamilton Thorne Biosciences、Integrated DNA Technologies、Microchip Biotechnologies、Myriad Genetics、Commonwealth Biotechnologies、ZS Genetics、Pacific Biosciences） ・結論 |
Cancer genome sequencing refers to a method used to identify the complete DNA or RNA sequence of cancer cells based on the sequencing of a single, homogeneous or heterogeneous group of tumor cells.
It is a laboratory technique that characterizes DNA or RNA sequences of primary tumor tissue, the tumor micro environment (such as stromal / fibroblast cells), adjacent or distal normal tissue, or metastatic tumor sites. This technique generates information related to identification of nucleotide bases (DNA or RNA), mutation status, copy number and sequence variants, as well as structural variations including fusion genes and chromosomal translocations.
Market Analysis and Insights: Global Cancer Genome Sequencing Market
The global Cancer Genome Sequencing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Genome Sequencing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Genome Sequencing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Genome Sequencing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Genome Sequencing market.
Global Cancer Genome Sequencing Scope and Market Size
Cancer Genome Sequencing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Genome Sequencing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Second generation
Third generation
Segment by Application
Treatment
Research
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Agilent Technologies
GE Healthcare Life Sciences
Johnson & Johnson
LI-COR Biosciences
Abbott Laboratories
Beckman Coulter
Bayer
Hamilton Thorne Biosciences
Integrated DNA Technologies
LI-COR Biosciences
Abbott Laboratories
Commonwealth Biotechnologies
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Genome Sequencing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Second generation
1.2.3 Third generation
1.3 Market by Application
1.3.1 Global Cancer Genome Sequencing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Treatment
1.3.3 Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Genome Sequencing Market Perspective (2016-2027)
2.2 Cancer Genome Sequencing Growth Trends by Regions
2.2.1 Cancer Genome Sequencing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cancer Genome Sequencing Historic Market Share by Regions (2016-2021)
2.2.3 Cancer Genome Sequencing Forecasted Market Size by Regions (2022-2027)
2.3 Cancer Genome Sequencing Industry Dynamic
2.3.1 Cancer Genome Sequencing Market Trends
2.3.2 Cancer Genome Sequencing Market Drivers
2.3.3 Cancer Genome Sequencing Market Challenges
2.3.4 Cancer Genome Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Genome Sequencing Players by Revenue
3.1.1 Global Top Cancer Genome Sequencing Players by Revenue (2016-2021)
3.1.2 Global Cancer Genome Sequencing Revenue Market Share by Players (2016-2021)
3.2 Global Cancer Genome Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cancer Genome Sequencing Revenue
3.4 Global Cancer Genome Sequencing Market Concentration Ratio
3.4.1 Global Cancer Genome Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Genome Sequencing Revenue in 2020
3.5 Cancer Genome Sequencing Key Players Head office and Area Served
3.6 Key Players Cancer Genome Sequencing Product Solution and Service
3.7 Date of Enter into Cancer Genome Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Genome Sequencing Breakdown Data by Type
4.1 Global Cancer Genome Sequencing Historic Market Size by Type (2016-2021)
4.2 Global Cancer Genome Sequencing Forecasted Market Size by Type (2022-2027)
5 Cancer Genome Sequencing Breakdown Data by Application
5.1 Global Cancer Genome Sequencing Historic Market Size by Application (2016-2021)
5.2 Global Cancer Genome Sequencing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cancer Genome Sequencing Market Size (2016-2027)
6.2 North America Cancer Genome Sequencing Market Size by Type
6.2.1 North America Cancer Genome Sequencing Market Size by Type (2016-2021)
6.2.2 North America Cancer Genome Sequencing Market Size by Type (2022-2027)
6.2.3 North America Cancer Genome Sequencing Market Size by Type (2016-2027)
6.3 North America Cancer Genome Sequencing Market Size by Application
6.3.1 North America Cancer Genome Sequencing Market Size by Application (2016-2021)
6.3.2 North America Cancer Genome Sequencing Market Size by Application (2022-2027)
6.3.3 North America Cancer Genome Sequencing Market Size by Application (2016-2027)
6.4 North America Cancer Genome Sequencing Market Size by Country
6.4.1 North America Cancer Genome Sequencing Market Size by Country (2016-2021)
6.4.2 North America Cancer Genome Sequencing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Cancer Genome Sequencing Market Size (2016-2027)
7.2 Europe Cancer Genome Sequencing Market Size by Type
7.2.1 Europe Cancer Genome Sequencing Market Size by Type (2016-2021)
7.2.2 Europe Cancer Genome Sequencing Market Size by Type (2022-2027)
7.2.3 Europe Cancer Genome Sequencing Market Size by Type (2016-2027)
7.3 Europe Cancer Genome Sequencing Market Size by Application
7.3.1 Europe Cancer Genome Sequencing Market Size by Application (2016-2021)
7.3.2 Europe Cancer Genome Sequencing Market Size by Application (2022-2027)
7.3.3 Europe Cancer Genome Sequencing Market Size by Application (2016-2027)
7.4 Europe Cancer Genome Sequencing Market Size by Country
7.4.1 Europe Cancer Genome Sequencing Market Size by Country (2016-2021)
7.4.2 Europe Cancer Genome Sequencing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cancer Genome Sequencing Market Size (2016-2027)
8.2 Asia-Pacific Cancer Genome Sequencing Market Size by Type
8.2.1 Asia-Pacific Cancer Genome Sequencing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cancer Genome Sequencing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cancer Genome Sequencing Market Size by Type (2016-2027)
8.3 Asia-Pacific Cancer Genome Sequencing Market Size by Application
8.3.1 Asia-Pacific Cancer Genome Sequencing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cancer Genome Sequencing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cancer Genome Sequencing Market Size by Application (2016-2027)
8.4 Asia-Pacific Cancer Genome Sequencing Market Size by Region
8.4.1 Asia-Pacific Cancer Genome Sequencing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cancer Genome Sequencing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cancer Genome Sequencing Market Size (2016-2027)
9.2 Latin America Cancer Genome Sequencing Market Size by Type
9.2.1 Latin America Cancer Genome Sequencing Market Size by Type (2016-2021)
9.2.2 Latin America Cancer Genome Sequencing Market Size by Type (2022-2027)
9.2.3 Latin America Cancer Genome Sequencing Market Size by Type (2016-2027)
9.3 Latin America Cancer Genome Sequencing Market Size by Application
9.3.1 Latin America Cancer Genome Sequencing Market Size by Application (2016-2021)
9.3.2 Latin America Cancer Genome Sequencing Market Size by Application (2022-2027)
9.3.3 Latin America Cancer Genome Sequencing Market Size by Application (2016-2027)
9.4 Latin America Cancer Genome Sequencing Market Size by Country
9.4.1 Latin America Cancer Genome Sequencing Market Size by Country (2016-2021)
9.4.2 Latin America Cancer Genome Sequencing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Genome Sequencing Market Size (2016-2027)
10.2 Middle East & Africa Cancer Genome Sequencing Market Size by Type
10.2.1 Middle East & Africa Cancer Genome Sequencing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cancer Genome Sequencing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cancer Genome Sequencing Market Size by Type (2016-2027)
10.3 Middle East & Africa Cancer Genome Sequencing Market Size by Application
10.3.1 Middle East & Africa Cancer Genome Sequencing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cancer Genome Sequencing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cancer Genome Sequencing Market Size by Application (2016-2027)
10.4 Middle East & Africa Cancer Genome Sequencing Market Size by Country
10.4.1 Middle East & Africa Cancer Genome Sequencing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cancer Genome Sequencing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Details
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Cancer Genome Sequencing Introduction
11.1.4 Agilent Technologies Revenue in Cancer Genome Sequencing Business (2016-2021)
11.1.5 Agilent Technologies Recent Development
11.2 GE Healthcare Life Sciences
11.2.1 GE Healthcare Life Sciences Company Details
11.2.2 GE Healthcare Life Sciences Business Overview
11.2.3 GE Healthcare Life Sciences Cancer Genome Sequencing Introduction
11.2.4 GE Healthcare Life Sciences Revenue in Cancer Genome Sequencing Business (2016-2021)
11.2.5 GE Healthcare Life Sciences Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Cancer Genome Sequencing Introduction
11.3.4 Johnson & Johnson Revenue in Cancer Genome Sequencing Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 LI-COR Biosciences
11.4.1 LI-COR Biosciences Company Details
11.4.2 LI-COR Biosciences Business Overview
11.4.3 LI-COR Biosciences Cancer Genome Sequencing Introduction
11.4.4 LI-COR Biosciences Revenue in Cancer Genome Sequencing Business (2016-2021)
11.4.5 LI-COR Biosciences Recent Development
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Details
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories Cancer Genome Sequencing Introduction
11.5.4 Abbott Laboratories Revenue in Cancer Genome Sequencing Business (2016-2021)
11.5.5 Abbott Laboratories Recent Development
11.6 Beckman Coulter
11.6.1 Beckman Coulter Company Details
11.6.2 Beckman Coulter Business Overview
11.6.3 Beckman Coulter Cancer Genome Sequencing Introduction
11.6.4 Beckman Coulter Revenue in Cancer Genome Sequencing Business (2016-2021)
11.6.5 Beckman Coulter Recent Development
11.7 Bayer
11.7.1 Bayer Company Details
11.7.2 Bayer Business Overview
11.7.3 Bayer Cancer Genome Sequencing Introduction
11.7.4 Bayer Revenue in Cancer Genome Sequencing Business (2016-2021)
11.7.5 Bayer Recent Development
11.8 Hamilton Thorne Biosciences
11.8.1 Hamilton Thorne Biosciences Company Details
11.8.2 Hamilton Thorne Biosciences Business Overview
11.8.3 Hamilton Thorne Biosciences Cancer Genome Sequencing Introduction
11.8.4 Hamilton Thorne Biosciences Revenue in Cancer Genome Sequencing Business (2016-2021)
11.8.5 Hamilton Thorne Biosciences Recent Development
11.9 Integrated DNA Technologies
11.9.1 Integrated DNA Technologies Company Details
11.9.2 Integrated DNA Technologies Business Overview
11.9.3 Integrated DNA Technologies Cancer Genome Sequencing Introduction
11.9.4 Integrated DNA Technologies Revenue in Cancer Genome Sequencing Business (2016-2021)
11.9.5 Integrated DNA Technologies Recent Development
11.10 Microchip Biotechnologies
11.10.1 Microchip Biotechnologies Company Details
11.10.2 Microchip Biotechnologies Business Overview
11.10.3 Microchip Biotechnologies Cancer Genome Sequencing Introduction
11.10.4 Microchip Biotechnologies Revenue in Cancer Genome Sequencing Business (2016-2021)
11.10.5 Microchip Biotechnologies Recent Development
11.11 Myriad Genetics
11.11.1 Myriad Genetics Company Details
11.11.2 Myriad Genetics Business Overview
11.11.3 Myriad Genetics Cancer Genome Sequencing Introduction
11.11.4 Myriad Genetics Revenue in Cancer Genome Sequencing Business (2016-2021)
11.11.5 Myriad Genetics Recent Development
11.12 Commonwealth Biotechnologies
11.12.1 Commonwealth Biotechnologies Company Details
11.12.2 Commonwealth Biotechnologies Business Overview
11.12.3 Commonwealth Biotechnologies Cancer Genome Sequencing Introduction
11.12.4 Commonwealth Biotechnologies Revenue in Cancer Genome Sequencing Business (2016-2021)
11.12.5 Commonwealth Biotechnologies Recent Development
11.13 ZS Genetics
11.13.1 ZS Genetics Company Details
11.13.2 ZS Genetics Business Overview
11.13.3 ZS Genetics Cancer Genome Sequencing Introduction
11.13.4 ZS Genetics Revenue in Cancer Genome Sequencing Business (2016-2021)
11.13.5 ZS Genetics Recent Development
11.14 Pacific Biosciences
11.14.1 Pacific Biosciences Company Details
11.14.2 Pacific Biosciences Business Overview
11.14.3 Pacific Biosciences Cancer Genome Sequencing Introduction
11.14.4 Pacific Biosciences Revenue in Cancer Genome Sequencing Business (2016-2021)
11.14.5 Pacific Biosciences Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cancer Genome Sequencing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Second generation
Table 3. Key Players of Third generation
Table 4. Global Cancer Genome Sequencing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Cancer Genome Sequencing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cancer Genome Sequencing Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Cancer Genome Sequencing Market Share by Regions (2016-2021)
Table 8. Global Cancer Genome Sequencing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Cancer Genome Sequencing Market Share by Regions (2022-2027)
Table 10. Cancer Genome Sequencing Market Trends
Table 11. Cancer Genome Sequencing Market Drivers
Table 12. Cancer Genome Sequencing Market Challenges
Table 13. Cancer Genome Sequencing Market Restraints
Table 14. Global Cancer Genome Sequencing Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Cancer Genome Sequencing Market Share by Players (2016-2021)
Table 16. Global Top Cancer Genome Sequencing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Genome Sequencing as of 2020)
Table 17. Ranking of Global Top Cancer Genome Sequencing Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Cancer Genome Sequencing Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cancer Genome Sequencing Product Solution and Service
Table 21. Date of Enter into Cancer Genome Sequencing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cancer Genome Sequencing Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Cancer Genome Sequencing Revenue Market Share by Type (2016-2021)
Table 25. Global Cancer Genome Sequencing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Cancer Genome Sequencing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Cancer Genome Sequencing Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Cancer Genome Sequencing Revenue Market Share by Application (2016-2021)
Table 29. Global Cancer Genome Sequencing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Cancer Genome Sequencing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Cancer Genome Sequencing Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Cancer Genome Sequencing Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Cancer Genome Sequencing Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Cancer Genome Sequencing Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Cancer Genome Sequencing Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Cancer Genome Sequencing Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Cancer Genome Sequencing Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Cancer Genome Sequencing Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Cancer Genome Sequencing Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Cancer Genome Sequencing Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Cancer Genome Sequencing Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Cancer Genome Sequencing Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Cancer Genome Sequencing Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Cancer Genome Sequencing Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cancer Genome Sequencing Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cancer Genome Sequencing Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cancer Genome Sequencing Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Cancer Genome Sequencing Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Cancer Genome Sequencing Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Cancer Genome Sequencing Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Cancer Genome Sequencing Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Cancer Genome Sequencing Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Cancer Genome Sequencing Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Cancer Genome Sequencing Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Cancer Genome Sequencing Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Cancer Genome Sequencing Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cancer Genome Sequencing Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cancer Genome Sequencing Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cancer Genome Sequencing Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Cancer Genome Sequencing Market Size by Country (2022-2027) & (US$ Million)
Table 61. Agilent Technologies Company Details
Table 62. Agilent Technologies Business Overview
Table 63. Agilent Technologies Cancer Genome Sequencing Product
Table 64. Agilent Technologies Revenue in Cancer Genome Sequencing Business (2016-2021) & (US$ Million)
Table 65. Agilent Technologies Recent Development
Table 66. GE Healthcare Life Sciences Company Details
Table 67. GE Healthcare Life Sciences Business Overview
Table 68. GE Healthcare Life Sciences Cancer Genome Sequencing Product
Table 69. GE Healthcare Life Sciences Revenue in Cancer Genome Sequencing Business (2016-2021) & (US$ Million)
Table 70. GE Healthcare Life Sciences Recent Development
Table 71. Johnson & Johnson Company Details
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Cancer Genome Sequencing Product
Table 74. Johnson & Johnson Revenue in Cancer Genome Sequencing Business (2016-2021) & (US$ Million)
Table 75. Johnson & Johnson Recent Development
Table 76. LI-COR Biosciences Company Details
Table 77. LI-COR Biosciences Business Overview
Table 78. LI-COR Biosciences Cancer Genome Sequencing Product
Table 79. LI-COR Biosciences Revenue in Cancer Genome Sequencing Business (2016-2021) & (US$ Million)
Table 80. LI-COR Biosciences Recent Development
Table 81. Abbott Laboratories Company Details
Table 82. Abbott Laboratories Business Overview
Table 83. Abbott Laboratories Cancer Genome Sequencing Product
Table 84. Abbott Laboratories Revenue in Cancer Genome Sequencing Business (2016-2021) & (US$ Million)
Table 85. Abbott Laboratories Recent Development
Table 86. Beckman Coulter Company Details
Table 87. Beckman Coulter Business Overview
Table 88. Beckman Coulter Cancer Genome Sequencing Product
Table 89. Beckman Coulter Revenue in Cancer Genome Sequencing Business (2016-2021) & (US$ Million)
Table 90. Beckman Coulter Recent Development
Table 91. Bayer Company Details
Table 92. Bayer Business Overview
Table 93. Bayer Cancer Genome Sequencing Product
Table 94. Bayer Revenue in Cancer Genome Sequencing Business (2016-2021) & (US$ Million)
Table 95. Bayer Recent Development
Table 96. Hamilton Thorne Biosciences Company Details
Table 97. Hamilton Thorne Biosciences Business Overview
Table 98. Hamilton Thorne Biosciences Revenue in Cancer Genome Sequencing Business (2016-2021) & (US$ Million)
Table 99. Hamilton Thorne Biosciences Recent Development
Table 100. Integrated DNA Technologies Company Details
Table 101. Integrated DNA Technologies Business Overview
Table 102. Integrated DNA Technologies Cancer Genome Sequencing Product
Table 103. Integrated DNA Technologies Revenue in Cancer Genome Sequencing Business (2016-2021) & (US$ Million)
Table 104. Integrated DNA Technologies Recent Development
Table 105. Microchip Biotechnologies Company Details
Table 106. Microchip Biotechnologies Business Overview
Table 107. Microchip Biotechnologies Cancer Genome Sequencing Product
Table 108. Microchip Biotechnologies Revenue in Cancer Genome Sequencing Business (2016-2021) & (US$ Million)
Table 109. Microchip Biotechnologies Recent Development
Table 110. Myriad Genetics Company Details
Table 111. Myriad Genetics Business Overview
Table 112. Myriad Genetics Cancer Genome Sequencing Product
Table 113. Myriad Genetics Revenue in Cancer Genome Sequencing Business (2016-2021) & (US$ Million)
Table 114. Myriad Genetics Recent Development
Table 115. Commonwealth Biotechnologies Company Details
Table 116. Commonwealth Biotechnologies Business Overview
Table 117. Commonwealth Biotechnologies Cancer Genome Sequencing Product
Table 118. Commonwealth Biotechnologies Revenue in Cancer Genome Sequencing Business (2016-2021) & (US$ Million)
Table 119. Commonwealth Biotechnologies Recent Development
Table 120. ZS Genetics Company Details
Table 121. ZS Genetics Business Overview
Table 122. ZS Genetics Cancer Genome Sequencing Product
Table 123. ZS Genetics Revenue in Cancer Genome Sequencing Business (2016-2021) & (US$ Million)
Table 124. ZS Genetics Recent Development
Table 125. Pacific Biosciences Company Details
Table 126. Pacific Biosciences Business Overview
Table 127. Pacific Biosciences Cancer Genome Sequencing Product
Table 128. Pacific Biosciences Revenue in Cancer Genome Sequencing Business (2016-2021) & (US$ Million)
Table 129. Pacific Biosciences Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Genome Sequencing Market Share by Type: 2020 VS 2027
Figure 2. Second generation Features
Figure 3. Third generation Features
Figure 4. Global Cancer Genome Sequencing Market Share by Application: 2020 VS 2027
Figure 5. Treatment Case Studies
Figure 6. Research Case Studies
Figure 7. Cancer Genome Sequencing Report Years Considered
Figure 8. Global Cancer Genome Sequencing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Cancer Genome Sequencing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Cancer Genome Sequencing Market Share by Regions: 2020 VS 2027
Figure 11. Global Cancer Genome Sequencing Market Share by Regions (2022-2027)
Figure 12. Global Cancer Genome Sequencing Market Share by Players in 2020
Figure 13. Global Top Cancer Genome Sequencing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Genome Sequencing as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Cancer Genome Sequencing Revenue in 2020
Figure 15. Global Cancer Genome Sequencing Revenue Market Share by Type (2016-2021)
Figure 16. Global Cancer Genome Sequencing Revenue Market Share by Type (2022-2027)
Figure 17. North America Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Cancer Genome Sequencing Market Share by Type (2016-2027)
Figure 19. North America Cancer Genome Sequencing Market Share by Application (2016-2027)
Figure 20. North America Cancer Genome Sequencing Market Share by Country (2016-2027)
Figure 21. United States Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Cancer Genome Sequencing Market Share by Type (2016-2027)
Figure 25. Europe Cancer Genome Sequencing Market Share by Application (2016-2027)
Figure 26. Europe Cancer Genome Sequencing Market Share by Country (2016-2027)
Figure 27. Germany Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Cancer Genome Sequencing Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Cancer Genome Sequencing Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Cancer Genome Sequencing Market Share by Region (2016-2027)
Figure 37. China Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Cancer Genome Sequencing Market Share by Type (2016-2027)
Figure 45. Latin America Cancer Genome Sequencing Market Share by Application (2016-2027)
Figure 46. Latin America Cancer Genome Sequencing Market Share by Country (2016-2027)
Figure 47. Mexico Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Cancer Genome Sequencing Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Cancer Genome Sequencing Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Cancer Genome Sequencing Market Share by Country (2016-2027)
Figure 53. Turkey Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Agilent Technologies Revenue Growth Rate in Cancer Genome Sequencing Business (2016-2021)
Figure 57. GE Healthcare Life Sciences Revenue Growth Rate in Cancer Genome Sequencing Business (2016-2021)
Figure 58. Johnson & Johnson Revenue Growth Rate in Cancer Genome Sequencing Business (2016-2021)
Figure 59. LI-COR Biosciences Revenue Growth Rate in Cancer Genome Sequencing Business (2016-2021)
Figure 60. Abbott Laboratories Revenue Growth Rate in Cancer Genome Sequencing Business (2016-2021)
Figure 61. Beckman Coulter Revenue Growth Rate in Cancer Genome Sequencing Business (2016-2021)
Figure 62. Bayer Revenue Growth Rate in Cancer Genome Sequencing Business (2016-2021)
Figure 63. Hamilton Thorne Biosciences Revenue Growth Rate in Cancer Genome Sequencing Business (2016-2021)
Figure 64. Integrated DNA Technologies Revenue Growth Rate in Cancer Genome Sequencing Business (2016-2021)
Figure 65. Microchip Biotechnologies Revenue Growth Rate in Cancer Genome Sequencing Business (2016-2021)
Figure 66. Myriad Genetics Revenue Growth Rate in Cancer Genome Sequencing Business (2016-2021)
Figure 67. Commonwealth Biotechnologies Revenue Growth Rate in Cancer Genome Sequencing Business (2016-2021)
Figure 68. ZS Genetics Revenue Growth Rate in Cancer Genome Sequencing Business (2016-2021)
Figure 69. Pacific Biosciences Revenue Growth Rate in Cancer Genome Sequencing Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界のシングルセルゲノムシーケンシング技術市場規模・現状・予測（2021年-2027年） Single-Cell Genome Sequencing Technology is a new technology to amplify and sequence the whole genome at the single cell level. The principle is to amplify a small amount of genomic DNA from isolated single cells, obtain high-coverage complete genomes, and then perform high-throughput sequencing to …- 世界の単一細胞ゲノムシーケンス市場 2021：企業別、地域別、種類・用途別 The Single-Cell Genome Sequencing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界のデジタルゲノム市場規模・現状・予測（2021年-2027年） Personal genomics is the branch of science giving insight into human metabolism and disease strains based on individual genetic traits with familial genetics playing a contributory role. Segmentation of digital genome market by Component Type comprises hardware, software and services. Digital genomi…
- 世界の次世代シーケンシング市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Next-Generation Sequencing Market The global Next-Generation Sequencing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, …
- 世界の全ゲノム増幅市場規模・現状・予測（2021年-2027年） The global Whole genome amplification market report provides analysis and insights on Whole genome amplification kits and consumables. Commercially available Whole genome amplification kits are based on Single cell WGA kits, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and others. M…